Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)

China flag China · Delayed Price · Currency is CNY
29.07
+0.08 (0.28%)
At close: Jun 12, 2025, 2:57 PM CST
-3.10%
Market Cap 4.64B
Revenue (ttm) 478.74M
Net Income (ttm) 212.91M
Shares Out 160.56M
EPS (ttm) 1.47
PE Ratio 19.67
Forward PE n/a
Dividend 1.50 (5.16%)
Ex-Dividend Date Jun 10, 2025
Volume 2,648,005
Average Volume 4,726,896
Open 28.99
Previous Close 28.99
Day's Range 28.77 - 29.35
52-Week Range 20.50 - 39.50
Beta n/a
RSI 48.45
Earnings Date Jul 30, 2025

About SHA:603207

Shanghai Xiao Fang Pharmaceutical Co., Ltd produces and sells medicines in China. It offers medicines in the areas of gastroenterology, dermatology, orthopedics, otorhinolaryngology, and disinfection. Shanghai Xiao Fang Pharmaceutical Co., Ltd was founded in 1993 and is based in Shanghai, China. [Read more]

Industry Pharmaceutical Preparations
Founded 1993
Employees 404
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603207
Full Company Profile

Financial Performance

In 2024, SHA:603207's revenue was 474.58 million, an increase of 0.57% compared to the previous year's 471.87 million. Earnings were 205.27 million, an increase of 0.81%.

Financial Statements

News

There is no news available yet.